secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000950170-23-027305
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health adjourns annual meeting to June 14; seeks more votes on reverse split and key proposals
--------------------------------------------------------------------------------

- Annual meeting on June 6, 2023 adjourned after only adjournment proposal approved; votes on director election, reverse split (1:5–1:30), and auditor ratification deferred to June 14.
- Reverse stock split proposal authorizes Board to determine ratio within 12 months without further shareholder approval.
- Record date remains April 13, 2023; shareholders urged to vote online at virtualshareholdermeeting.com/TIVC2023.
- CEO needs additional votes for key measures; Board unanimously voted to reconvene on June 14 at 1:00 p.m. PT.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023027305/0000950170-23-027305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023027305/tivc-20230606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer